89 results
Page of 8
  • A011104 / 6694

    Effect of Preoperative Breast MRI on Surgical Outcomes, Costs and Quality of Life of Women with Breast Cancer. The J. Phillip Citta Cancer Center provides patients access to national and regional clinical research studies. The availability of these studies in the treatment of cancer, chemoprevention, and supportive care allow patients the option to participate in the latest treatment options including investigational drugs.

    For more information, please call Lennette Gonzales, RN, MSHS, OCN, CCRP, Oncology Research Registered Nurse as the J. Phillip Citta Regional Cancer Center

    For inquiries, call (732) 557-8294
    • Community Medical Center
  • A011202

    A Randomized Phase III Trial Comparing Axillary Dissection To Axillary Radiation In Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

    For inquiries, call (973) 926-7230
    • Newark Beth Israel Medical Center
  • A011202

    A Randomized Phase III Trial Comparing Axillary Lymph Node Dissection to Axillary Radiation in Breast Cancer Patients (cT1-3 N1) Who Have Positive Sentinel Lymph Node Disease After Neoadjuvant Chemotherapy

    For inquiries, call (908) 685-2481
    • RWJ University Hospital Somerset
  • A011401

    Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

    The Breast cancer Weight Loss (BWEL) Study

    For inquiries at Newark Beth Israel Medical Center, call (973) 926-7230

    For inquiries at Monmouth Medical Center, call (732) 923-6564

    • Monmouth Medical Center
    • Newark Beth Israel Medical Center
  • A011401 / BWel Trial

    Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women with Early Breast Cancer

    For inquiries, call (908) 685-2481
    • RWJ University Hospital Somerset
  • A011502 / ABC Trial

    A Randomized Phase III Double-Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

    For inquiries at Newark Beth Israel Medical Center, call (973) 926-7230

    For inquiries at Monmouth Medical Center, call (732) 923-6564

    For inquiries at RWJ Somerset Medical Center, call (908) 685-2481

    • Monmouth Medical Center
    • Newark Beth Israel Medical Center
    • RWJ University Hospital Somerset
  • A041702

    A041702 A Randomized Phase III Study of Ibrutinib Plus Obinutuzumab Versus Ibrutinib plus Venetoclax and Obinutuzumab in Untreated Older Patients (≥ 70 Years of Age) with Chronic Lymphocytic Leukemia (CLL)” (NCT # NCT03737981)

    For inquiries, call (732) 923-6564
    • Monmouth Medical Center
  • A081105

    Randomized Study of Erlotinib Vs Observation in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)

    For inquiries, call (908) 685-2481
    • RWJ University Hospital Somerset
  • A081105

    A Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-small Cell Lung Cancer (NSCLC). The J. Phillip Citta Cancer Center provides patients access to national and regional clinical research studies. The availability of these studies in the treatment of cancer, chemoprevention, and supportive care allow patients the option to participate in the latest treatment options including investigational drugs.

    For more information, please call Lennette Gonzales, RN, MSHS, OCN, CCRP, Oncology Research Registered Nurse as the J. Phillip Citta Regional Cancer Center

    For inquiries, call (732) 557-8294
    • Community Medical Center
  • A151216

    Adjuvant Lung Cancer Enrichment Marker Identification and Sequencing Trial (ALCHEMIST). The J. Phillip Citta Cancer Center provides patients access to national and regional clinical research studies. The availability of these studies in the treatment of cancer, chemoprevention, and supportive care allow patients the option to participate in the latest treatment options including investigational drugs.

    For more information, please call Lennette Gonzales, RN, MSHS, OCN, CCRP, Oncology Research Registered Nurse as the J. Phillip Citta Regional Cancer Center

    For inquiries, call (732) 557-8294
    • Community Medical Center
  • A151216 ALCHEMIST

    Genetic Testing in Screening Patients With Stage IB-IIIA Non-Small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)

    For inquiries at RWJ University Hospital Somerset, call (908) 685-2481

    For inquiries at Monmouth Medical Center, call (732) 923-6564

    • Monmouth Medical Center
    • RWJ University Hospital Somerset
  • ACURATE

    Evaluation of the safety and efficacy of the Acurate valve for transcatheter aortic valve replacement (TAVR)

    Type: Device trial

    Principal Investigator: Mark Russo, MD

    Trial is open for enrollment

    For inquiries, call (732) 235-9215

    • Rutgers Robert Wood Johnson Medical School
    • Robert Wood Johnson University Hospital
Page of 8